From January 1, 2023 to February 10, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 109,064 shares, representing 0.89% for KRW 9,895.01 million under the buyback announced on February 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
101,400 KRW | -1.74% | -0.49% | -22.54% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.54% | 945M | |
+21.60% | 43.81B | |
+25.56% | 23.01B | |
+18.81% | 15.27B | |
+10.30% | 13.68B | |
+43.73% | 11.96B | |
-7.49% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.26% | 5.59B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.